Name: Latest research reports of Biocon Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: ICICI Securities Limited

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Strong Performer, Getting Expensive

389.8000 -5.05 (-1.28%)

NSE Feb 27, 2026 15:31 PM

33.95% Gain from 52W Low

Volume: 4.4M

Biocon Ltd.

26 Oct 2018

389.80

-1.28%

Biocon

Buy: Biocon Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Strong Q2 numbers were on the back of 136% YoY growth in Biologics segment led by commercial launch of biosimilar...

Axis Direct decreased Buy price target of Biocon Ltd. to 435.0 on 16 Feb, 2026.